I hope so, just bought 40,000 shares here under 0.43
Recent CRDF News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:16:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:15:28 PM
- Cardiff Oncology to Host Key Opinion Leader Discussion Focusing on First-Line RAS-mutated Metastatic Colorectal Cancer • GlobeNewswire Inc. • 03/20/2026 11:00:00 AM
- Cardiff Oncology to Present Preclinical Data with Highly Specific PLK1 Inhibitor Onvansertib at the 2026 AACR Annual Meeting • GlobeNewswire Inc. • 03/19/2026 11:00:00 AM
- Cardiff Oncology to Participate in Three Upcoming Investor Conferences • GlobeNewswire Inc. • 02/26/2026 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 01:30:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/24/2026 10:09:22 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/24/2026 10:07:45 PM
- Cardiff Oncology Reports Full Year 2025 Results and Provides Business Update • GlobeNewswire Inc. • 02/24/2026 09:30:00 PM
- Cardiff Oncology to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/19/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:02:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:01:02 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2026 09:00:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/27/2026 09:01:24 PM
- Cardiff Oncology Announces Positive Update from its Randomized Phase 2 Trial of Onvansertib in First-line RAS-mutated mCRC • GlobeNewswire Inc. • 01/27/2026 12:05:00 PM
- Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development • GlobeNewswire Inc. • 01/27/2026 12:00:00 PM
- GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era • GlobeNewswire Inc. • 12/12/2025 03:31:03 PM
- Sidoti Events, LLC's Year-End Virtual Investor Conference • ACCESS Newswire • 12/09/2025 05:48:00 PM
- Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025 • GlobeNewswire Inc. • 12/08/2025 09:05:00 PM
- Cardiff Oncology to Present at Sidoti’s Year-End Virtual Investor Conference • GlobeNewswire Inc. • 12/08/2025 12:00:00 PM
- Cardiff Oncology to Present at the Piper Sandler 37th Annual Healthcare Conference • GlobeNewswire Inc. • 11/24/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2025 09:08:38 PM
- Cardiff Oncology Reports Third Quarter 2025 Results and Provides Business Update • GlobeNewswire Inc. • 11/06/2025 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 09:00:49 PM
- Cardiff Oncology to Participate in Two Upcoming Investor Conferences • GlobeNewswire Inc. • 11/04/2025 09:01:00 PM
